Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Zeitraum:
Zeichenmodus:
| Volumen | 17.954 |
|
|||||
| News | - | ||||||
| Tageshoch | 6,50 | Niedrig Hoch |
|||||
| Tagestief | 6,10 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Lipocine Inc | LPCN | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,41 | 6,79% | 6,45 | 18:44:19 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 6,10 | 6,10 | 6,50 | 6,04 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 402 | 17.954 | US$ 6,26 | US$ 112.363 | - | 2,3101 - 7,15 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 18:44:07 | 27 | US$ 6,45 | USD |
Finanzwerte LPCN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 33,22M | 5,32M | - | -2,85M | -16,35M | -3,08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Lipocine
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 09.5.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Financial Results for the First Quarter.. |
| 09.5.2024 | 12:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09.5.2024 | 12:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.5.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Late Breaking Oral Presentation of Data.. |
| 08.5.2024 | 12:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.5.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Completion of Dosing in Pivotal Study of.. |
| 11.4.2024 | 13:00 | PR Newswire (US) | Lipocine Announces Positive LPCN 2401 Clinical Results.. |
| 28.3.2024 | 13:00 | PR Newswire (US) | Lipocine Announces Positive Week 52 Results from LPCN 1148.. |
| 25.3.2024 | 13:00 | PR Newswire (US) | Lipocine Announces First Cohort Dosed in Pivotal Study of.. |
| 07.3.2024 | 23:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.3.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Financial Results for the Full Year Ended.. |
| 07.3.2024 | 12:08 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Lipocine
Keine Diskussionen Gefunden.Neuen Thread Erstellen
LPCN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 5,44 | 6,50 | 5,1103 | 5,71 | 28.293 | 1,01 | 18,57% |
| 1 Monat | 5,19 | 6,50 | 4,38 | 5,02 | 32.555 | 1,26 | 24,28% |
| 3 Monate | 3,75 | 7,15 | 3,20 | 5,72 | 70.060 | 2,70 | 72,00% |
| 6 Monate | 2,57 | 7,15 | 2,38 | 5,11 | 46.350 | 3,88 | 150,97% |
| 1 Jahr | 3,77 | 7,15 | 2,3101 | 4,94 | 70.667 | 2,68 | 71,09% |
| 3 Jahre | 23,46 | 32,13 | 2,3101 | 17,94 | 351.008 | -17,01 | -72,51% |
| 5 Jahre | 31,79 | 59,50 | 2,3101 | 23,42 | 975.153 | -25,34 | -79,71% |
